medigraphic.com

2015, Number S1

<< Back Next >>

Rev Mex Anest 2015; 38 (S1)

Anesthetic considerations for the management of drugs in the senile patient during the perioperative period

Vásquez-Márquez I, Castellanos-Olivares A

Language: Spanish
References: 22
Page: 178-188
PDF size: 221.51 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Bettelli G. Preoperative evaluation in geriatric surgery: comorbidity functional status and Pharmacological history. Minerva Anestesiol. 2011;77:637-646.

  2. Griffiths R, Beech F, Brown AI, Dhesi J, Foo I, Goodall J. AAGBI safety guideline peri-operative care of the elderly. Anesthesia. 2014;69:81-98.

  3. Okuyama A, Martowirono K, Bijnen B. Assessing the patient safety competencies of healthcare professionals: a systematic review. Br J Med. 2011;20:991-1000.

  4. Boeker EB, Boer M, Kiewiet JJ, Lie-A-Huen L, Dijkgraaf MG, Boermeester MA. Occurrence and preventability of adverse drug events in surgical patients: a systematic review of literature. Health Serv Res. 2013;28:13:364.

  5. Cruz-Pardos P, Fernández-Riveira C, Garutti I. Betabloqueantes: utilidad perioperatoria en cirugía no cardíaca. Rev Esp Anestesiol Reanim. 2005;52:617-626.

  6. Singh A, Antognini JF. Perioperative pharmacology in elderly patients. Curr Opin Anaesthesiol. 2010;23:449-454.

  7. Wooten JM. Pharmacotherapy considerations in elderly adults. South Med J. 2012;105:437-445.

  8. Rivera R, Antognini JF. Perioperative drug therapy in elderly. Anaesthesiol. 2009;110:1176-1181.

  9. McLachlan AJ, Pont LG. Drug metabolism in older people. A key consideration in achieving optimal outcomes with medicines. J Gerontol A Biol Sci Med Sci. 2012;67:175-180.

  10. Dimitrow MS, Airaksinen MS, Kivelä LS, Lyles AS, Leikola SN. Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review. J of Amer Geriatrics Soc. 2011;59:1521-1530.

  11. Górriz T JL, Beltrán CS. Valoración de afección renal, disfunción renal aguda e hiperpotasemia por fármacos usados en cardiología y nefrotoxicidad por contrastes. Rev Esp Cardiol. 2011;64:1182-1192.

  12. Brubaker HP, Kitzman WD. Chronotropic incompetence: causes, consequences, and management. Circulation. 2011;123:1010-1020.

  13. Marsden CD, Jenner P. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med. 2009;39:1055-1072.

  14. Ralph IE, Jeffrey KA. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255-1259.

  15. Arnaiz JA, Carné X, Riba N, Codina C, Ribas J, Trilla A. The use of evidence in pharmacovigilance. Eur J Clin Pharmacol. 2001;57:89-91.

  16. Wester K, Jönsson KA, Spigset O, Druid H, Hägg S. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol. 2008;65:573-579.

  17. Hartshorn EA. Drug interaction. Ann Pharm. 2006;40:112-113.

  18. Egger SS, Drewe J, Schlienger RG. Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol. 2003;58:773-777.

  19. Köhler GL, Böger RH, Busse R. Drug-drug interactions in medical patients: effects of in hospital treatment and relation to multiple drug use. Int J Clin Pharmacol. 2000;38:504-513.

  20. Mahony OD, Sullivan DO, Byrne S, Connor MN, Ryan C, Gallagher P. Stopp/Start criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213-218.

  21. Fick D, Semla T, Beizer J, Brandt N, Dombrowski R, DuBeau CE. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616-631.

  22. Spell NO. Stopping and restarting medications in the preoperative period. Med Clin N Am. 2001;85:1117-1128.




2020     |     www.medigraphic.com